Company intelligence / Profile preview

CAS Ion Medical Technology

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

CAS Ion Medical Technology (CASHIM) specializes in heavy ion and proton radiotherapy systems. Its flagship product, the Heavy Ion Medical Machine (HIMM), is China's first self-developed heavy ion accelerator for cancer treatment, which received NMPA approval and is operational in clinical settings. The company is currently expanding its portfolio to include integrated carbon-proton and proton-helium ion therapy systems.

Therapeutic areas: Oncology
Modalities: DeviceRadiotherapy
Industry: Therapeutic Medical Devices

Partnerships

Institute of Modern Physics of the Chinese Academy of Sciences (IMP-CAS)Wuwei Tumor HospitalHuizhou Central People's Hospital

Beyond the preview

Go deeper on CAS Ion Medical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CAS Ion Medical Technology.

Explore the full profile